Understanding the Complexities of Anticancer Drugs Resistance
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Drug Development".
Deadline for manuscript submissions: 30 December 2025 | Viewed by 1685
Special Issue Editors
Interests: cancer epigenetics; molecular pathways; epi-drugs; genetic mutations; genetic engineering; targeted therapy; next-generation sequencing; tumor microenvironment
Special Issues, Collections and Topics in MDPI journals
Interests: epigenetics; molecular biology; cancer; RNA modifications; drug discovery; genomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Anticancer drug resistance is a major challenge in cancer therapy and significantly impacts patient outcomes. Genetic mutations play a pivotal role in drug resistance. Cancer cells acquire mutations that alter their DNA, enabling them to evade the effects of anticancer drugs. These mutations can affect drug targets, drug metabolism, and DNA repair mechanisms, rendering the drugs ineffective. Furthermore, some mutations can activate alternative signaling pathways that bypass the drugs' intended targets. The tumor microenvironment can also contribute to drug resistance by providing a protective niche for cancer cells. Tumor cells interact with immune cells, fibroblasts, and blood vessels, creating a complex network. This interaction can lead to the secretion of factors that promote drug resistance, such as cytokines and growth factors. Additionally, the tumor microenvironment can create physical barriers, such as a dense extracellular matrix, limiting drug penetration into the tumor. Understanding the mechanisms of drug resistance can drive the development of effective cancer treatments, including new drugs, combination therapies, and personalized medicine approaches. In this Special Issue of Cancers, we welcome original research articles or comprehensive reviews focusing on the complexities of anticancer drug resistance, including the mechanisms involved, the factors contributing to drug resistance, and the strategies to overcome drug resistance.
Dr. Mariarosaria Conte
Dr. Nunzio Del Gaudio
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
